A SIMPLE PROCEDURE FOR LARGE‐SCALE DENSITY SEPARATION OF BONE MARROW CELLS FOR TRANSPLANATION

T. Thomas,S. J. Abraham,G. Phillips,P. Lansdorp

DOI: https://doi.org/10.1097/00007890-199205000-00040

1992-05-01

Transplantation

Abstract:

What problem does this paper attempt to address?

THU0247 LRRN4: A NOVEL PROGNOSTIC BIOMARKER OF RENAL OUTCOME IN LUPUS NEPHRITIS PATIENTS

Heng Cao,Jin Lin

DOI: https://doi.org/10.1136/annrheumdis-2019-eular.802

IF: 27.973

2019-01-01

Annals of the Rheumatic Diseases

Abstract:Background: Lupus nephritis (LN) is the most common organ-threatening manifestation of systemic lupus erythematosus (SLE) and can result in kidney deterioration and end-stage renal disease (ESRD). Newly discovered biomarkers exhibit qualities of disease activity and damage, predict long term preservation of renal function. Objectives: Combine the transcriptomics profile of kidney with long-term renal outcome in LN patients, to explore the novel non-invasive predictive biomarker for renal outcome. Methods: The transcriptomics profile of kidney in 24 LN patients was obtained by using Affymetrix human HTA 2.0 gene expression chip. Random Forest method was used to screen the candidate mRNA biomarkers by correlate the gene expression profile with eGFR slope during the follow-up (Mean time 5.2±1.2 years). In addition, in an independent LN cohort enrolled 45 patients, qRT-PCR and immunochemistry staining was performed to validate the correlation of mRNA level and protein level of candidate gene with renal outcome. Results: (1) There were 3212 gene was regulated in LN kidney (Fold change>1.5, FDA Conclusion: LRRN4 in kidney may be used as a novel predictive biomarker of renal outcome in LN patients. References: [1] Dall’Era M, Cisternas MG, Smilek DE, et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol. 2015 May; 67(5):1305-13. [2] Misra R, Gupta R. Biomarkers in lupus nephritis. Int J Rheum Dis. 2015 Feb; 18(2):219-32. Disclosure of Interests: None declared
p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.

A. Olshan,M. Weissler,Hong Pei,Kathleen Conway

1997-07-01

Abstract:It has been suggested that the frequency, type, and location of p53 mutations (mutational spectra) can be linked to specific exogenous and endogenous carcinogenic agents and processes. Squamous cell carcinoma of the head and neck (SCCHN) provides an excellent tumor model to evaluate the utility of the p53 mutational spectra, given that it has well-defined and strong risk factors (tobacco and alcohol). The purpose of this analysis was to establish the pattern of p53 mutations in SCCHN and evaluate this mutational spectrum in comparison to the spectra for other cancers with similar and different risk factors, including cancers of the esophagus, lung, and colon. p53 mutational data were obtained from head and neck tumors collected at the University of North Carolina Hospitals and the published literature. A total of 14 of 33 tumors from the University of North Carolina Hospitals (42%) were found to have a p53 mutation. The alterations included three transversions, seven transitions, two deletions, and two suspected codon 47 polymorphisms. In general, SCCHN and esophageal cancer share a similar mutational pattern in contrast to colon cancer. These two aerodigestive tract cancers were statistically different from lung cancer, despite sharing tobacco as a major risk factor. For example, G-->T transversions, a mutation type considered to be characteristic of exogenous DNA-damaging agents including tobacco smoke carcinogens, varied among tobacco-related cancer sites (14% SCCHN, 11% esophageal, and 31% lung) in contrast to colon cancer (6%). The comparison of mutational spectra for SCCHN and other cancers indicates that the effects of both tobacco and alcohol exposure may yield a pattern of p53 mutations that reflects elements of both exogenous and endogenous exposures.
Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Huijing Wang,Lan Lan,Jianghua Chen,Liang Xiao,Fei Han

DOI: https://doi.org/10.1136/lupus-2022-000717

IF: 4.687

2022-01-01

Lupus Science & Medicine

Abstract:Objectives Lupus nephritis (LN) is a common and severe manifestation of SLE. Memory T (TM) cells have been implicated in the pathogenesis of SLE. This study aimed to investigate the clinical significance of T-cell subsets in a cohort of patients with LN. Method The peripheral blood T cells of 24 patients with LN and 13 patients with idiopathic membranous nephropathy (iMN) were analysed by flow cytometry. SLE disease activity was evaluated by SLE Disease Activity Index-2000 (SLEDAI-2K). Patients with LN were followed up for >6 months. Results Patients with LN presented lower frequency of CDC` cells and higher percentage of CD8(+) cells than patients with iMN, which was primarily due to lower CD4(+ )cell count. Interestingly, patients with LN under immunosuppressants had lower CD8(+)CD45R0 - TM frequency (p=0.007), fewer regulatory CD4(+) T cells (p=0.04) than those without immunosuppressants. Most CD4+ and CD8(+) TM cells in patients with LN showed an effector memory (C045RO(+)CCR7(+)) phenotype. The frequency of CD8(+)CD45R0(+) TM cells among the CD8(+) T cells was negatively correlated with white blood cell count, haemoglobin, platelet and serum levels of complements C3 and C4, but was positively correlated with serum IgG, erythrocyte sedimentation rate and SLEDAI score (p<0.05 each). Consistently, the frequency of CD8(+)CD45R0(+) TM cells was higher in patients with LN with positive antidouble-stranded DNA antibody, active renal disease, extrarenal manifestations and with sderotic glomeruli or moderate-to-severe mesangial hypercellularity in renal pathology (p<0.05). Additionally, CD8(+)CD45R0(+) TM cell frequency was significantly lower in patients with LN with renal complete remission than that in non-remission LN (18.7% vs 31.2%, p<0.05). None of these significant correlations was observed in CD4(+). TM cells. Conclusion The frequency of CD8(+) TM cells correlates with disease activity and treatment response to immunosuppressant in patients with LN. CD8(+) TM monitoring in patients with LN could provide more helpful indices for the monitoring and management of this disease.
Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation

Weiwei Chen,Wenchao Li,Zhuoya Zhang,Xiaojun Tang,Shufang Wu,Genhong Yao,Kang Li,Dandan Wang,Yuemei Xu,Ruihai Feng,Xiaoxiao Duan,Xiangshan Fan,Liwei Lu,WanJun Chen,Chaojun Li,Lingyun Sun

DOI: https://doi.org/10.1681/asn.2019090937

IF: 14.978

2020-01-01

Journal of the American Society of Nephrology

Abstract:Background Lipocalin-2 (LCN2) is an indicator of the severity of lupus nephritis (LN) and plays a pivotal role in immune responses, but it is not known if its effect on LN pathogenesis derives from regulating the immune imbalance of T lymphocyte subsets. Methods The expression of LCN2 in T cells and kidneys was assessed in renal biopsies from patients with LN. We investigated the relationship between LCN2 levels and development of LN and systemic illness by injecting anti-LCN2 antibodies into MRL/lprmice and analyzing pristane-treatedLCN2(-/-)mice. Results LCN2 is highly expressed in CD4(+)T cells and in renal tissues, and is associated with severe renal damage in patients with LN and in mice with experimental lupus. LCN2 promotes IFN-gamma overexpression in CD4(+)T cells through the IL-12/STAT4 pathway in an autocrine or paracrine manner. Both neutralization of LCN2 in MRL/lprmice and genetic depletion of LCN2 in pristane-induced lupus mice greatly ameliorate nephritis. The frequency and number of splenic and renal Th1 cells decrease in proportion to LN disease activity. Conversely, administration of LCN2 exacerbates the disease with significantly higher renal activity scores and increased numbers of Th1 cells. Conclusions LCN2 plays a crucial role in Th1 cell differentiation, and may present a potential therapeutic target for LN. Significance Statement Lipocalin-2 (LCN2) is an indicator of the severity of lupus nephritis (LN), but its exact role and the underlying mechanism of its association with the condition remain unclear. LCN2 is a key regulator of T helper type 1 (Th1) cell differentiation in the pathogenesis of LN, acting through the IL-12/signal transducer and activator of transcription 4 pathway in an autocrine or paracrine manner. Amelioration of nephritis in MRL/lprmice given LCN2-neutralizing antibodies and in pristane-treatedLCN2(-/-)mice, provides the first proof of concept that decreasing LCN2 protects against renal injury through dampening the Th1 response. LCN2 blockade may present a promising new strategy to attenuate LN.
A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis

Samir V. Parikh,Ana Malvar,John Shapiro,James M. Turman,Huijuan Song,Valeria Alberton,Bruno Lococo,Juan M. Mejia-Vilet,Sethu Madhavan,Jianying Zhang,Lianbo Yu,Anjali A. Satoskar,Dan Birmingham,Wael N. Jarjour,Brad H. Rovin,Latha P. Ganesan

DOI: https://doi.org/10.3389/fimmu.2021.621039

IF: 7.3

2021-02-17

Frontiers in Immunology

Abstract:The mechanisms that promote local inflammatory injury during lupus nephritis (LN) flare are largely unknown. Understanding the key immune cells that drive intrarenal inflammation will advance our knowledge of disease pathogenesis and inform the development of new therapeutics for LN management. In this study, we analyzed kidney biopsies from patients with proliferative LN and identified a novel inflammatory dendritic cell (infDC) population that is highly expressed in the LN kidney, but minimally present in healthy human kidneys. During an agnostic evaluation of immune transcript expression in the kidneys of patients with proliferative LN, the most abundantly overexpressed transcript from isolated glomeruli was FCER1G , which encodes the Fc receptor gamma chain (FcRγ). To identify the cell types expressing FcRγ that infiltrate the kidney in LN, studies were done on kidney biopsies from patients with active LN using confocal immunofluorescence (IF) microscopy. This showed that FcRγ is abundantly present in the periglomerular (PG) region of the kidney and to a lesser extent in the tubulointerstitium (TI). Further investigation of the surface markers of these cells showed that they were FcRγ + , MHC II + , CD11c + , CD163 + , CD5 − , DC-SIGN + , CD64 + , CD14 + , CD16 + , SIRPα + , CD206 − , CD68 − , CD123 − , CD3 − , and CD11b − , suggesting the cells were infDCs. Quantification of the infDCs showed an average 10-fold higher level of infDCs in the LN kidney compared to the healthy kidneys. Importantly, IF identified CD3 + T cells to be adjacent to these infDCs in the PG space of the LN kidney, whereas both cell types are minimally present in the healthy kidney. Thus, we have identified a previously undescribed DC in lupus kidneys that may interact with intrarenal T cells and play a role in the pathogenesis of kidney injury during LN flare.

immunology
TLR4+CXCR4+ Plasma Cells Drive Nephritis Development in Systemic Lupus Erythematosus

Kongyang Ma,Jingyi Li,Xiaohui Wang,Xiang Lin,Wenhan Du,Xi Yang,Fangxiang Mou,Yongfei Fang,Yanbin Zhao,Xiaoping Hong,Kwok Wah Chan,Xiaoming Zhang,Dongzhou Liu,Lingyun Sun,Liwei Lu

DOI: https://doi.org/10.1136/annrheumdis-2018-213615

IF: 27.973

2018-01-01

Annals of the Rheumatic Diseases

Abstract:ObjectivesIn patients with systemic lupus erythematosus (SLE), immune tolerance breakdown leads to autoantibody production and immune-complex glomerulonephritis. This study aimed to identify pathogenic plasma cells (PC) in the development of lupus nephritis.MethodsPC subsets in peripheral blood and renal tissue of patients with SLE and lupus mice were examined by flow cytometry and confocal microscopy, respectively. Sorting-purified PCs from lupus mice were adoptively transferred into Rag2-deficient recipients, in which immune-complex deposition and renal pathology were investigated. In culture, PCs from lupus mice and patients with SLE were treated with a TLR4 inhibitor and examined for autoantibody secretion by enzyme-linked immunospot assay (ELISPOT). Moreover, lupus mice were treated with a TLR4 inhibitor, followed by the assessment of serum autoantibody levels and glomerulonephritis activity.ResultsThe frequencies of TLR4+CXCR4+ PCs in peripheral blood and renal tissue were found significantly increased with the potent production of anti-dsDNA IgG, which were associated with severe renal damages in patients with SLE and mice with experimental lupus. Adoptive transfer of TLR4+CXCR4+ PCs from lupus mice led to autoantibody production and glomerulonephritis development in Rag2-deficient recipients. In culture, TLR4+CXCR4+ PCs from both lupus mice and patients with SLE showed markedly reduced anti-dsDNA IgG secretion on TLR4 blockade. Moreover, in vivo treatment with TLR4 inhibitor significantly attenuated autoantibody production and renal damages in lupus mice.ConclusionsThese findings demonstrate a pathogenic role of TLR4+CXCR4+ PCs in the development of lupus nephritis and may provide new therapeutic strategies for the treatment of SLE.
Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics

Lisha Mou,Fan Zhang,Xingjiao Liu,Ying Lu,Mengli Yue,Yupeng Lai,Zuhui Pu,Xiaoyan Huang,Meiying Wang

DOI: https://doi.org/10.3389/fimmu.2024.1309447

IF: 7.3

2024-05-25

Frontiers in Immunology

Abstract:Introduction: Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), presents significant challenges in patient management and treatment outcomes. The identification of novel LN-related biomarkers and therapeutic targets is critical to enhancing treatment outcomes and prognosis for patients. Methods: In this study, we analyzed single-cell expression data from LN (n=21) and healthy controls (n=3). A total of 143 differentially expressed genes were identified between the LN and control groups. Then, proteomics analysis of LN patients (n=9) and control (SLE patients without LN, n=11) revealed 55 differentially expressed genes among patients with LN and control group. We further utilizes protein-protein interaction network and functional enrichment analyses to elucidate the pivotal role of COL6A3 in key signaling pathways. Its diagnostic value is evaluate through its correlation with disease progression and renal function metrics, as well as Receiver Operating Characteristic Curve (ROC) analysis. Additionally, immunohistochemistry and qPCR experiments were performed to validate the expression of COL6A3 in LN. Results: By comparison of single-cell and proteomics data, we discovered that COL6A3 is significantly upregulated, highlighting it as a critical biomarker of LN. Our findings emphasize the substantial involvement of COL6A3 in the pathogenesis of LN, particularly noting its expression in mesangial cells. Through comprehensive protein-protein interaction network and functional enrichment analyses, we uncovered the pivotal role of COL6A3 in key signaling pathways including integrin-mediated signaling pathways, collagen-activated signaling pathways, and ECM-receptor interaction, suggesting potential therapeutic targets. The diagnostic utility is confirmed by its correlation with disease progression and renal function metrics of the glomerular filtration rate. ROC analysis further validates the diagnostic value of COL6A3, with the area under the ROC values of 0.879 in the in-house cohort, and 0.802 and 0.915 in tubular and glomerular external cohort samples, respectively. Furthermore, immunohistochemistry and qPCR experiments were consistent with those obtained from the single-cell RNA sequencing and proteomics studies. Discussion: These results proved that COL6A3 is a promising biomarker and therapeutic target, advancing personalized medicine strategies for LN.

immunology
Optimization of the design for beamline with fast polarization switching elliptically polarized undulators.

Jiefeng Cao,Yong Wang,Y. Zou,Xiangzhi Zhang,Yanqing Wu,R. Tai

DOI: https://doi.org/10.1107/S160057751600059X

IF: 2.557

2016-03-01

Journal of Synchrotron Radiation

Abstract:Fast switching of X-ray polarization with a lock-in amplifier is a good method for acquiring weak signals from background noise for X-ray magnetic circular dichroism (XMCD) experiments. The usual way to obtain a beam with fast polarization switching is to use two series of elliptically polarized undulators (tandem twin EPUs). The two EPUs generate two individual beams. Each beam has a different polarization and is fast switched into the beamline. It is very important to ensure that the energy resolution, the flux and the spot size at the sample of the two beams are equal in XMCD experiments. However, it is difficult in beamline design because the distances from the two EPUs to the beamline optics are different and the beamline is not switchable. In this work, a beamline design without an entrance slit for fast polarization switching EPUs is discussed. The energy resolution of the two beams can be tuned to be equal by minor rotation of the optics in the monochromator. The flux of the two beams can be balanced through separation blades X, Y in the exit slit, and by adjusting the position of the X blades along the beam. The spot size of the two beams can be adjusted to be equal by shifting the sample as well.
The immune cell landscape in kidneys of patients with lupus nephritis

Arnon Arazi,Deepak A. Rao,Celine C. Berthier,Anne Davidson,Yanyan Liu,Paul J. Hoover,Adam Chicoine,Thomas M. Eisenhaure,A. Helena Jonsson,Shuqiang Li,David J. Lieb,Fan Zhang,Kamil Slowikowski,Edward P. Browne,Akiko Noma,Danielle Sutherby,Scott Steelman,Dawn E. Smilek,Patti Tosta,William Apruzzese,Elena Massarotti,Maria Dall’Era,Meyeon Park,Diane L. Kamen,Richard A. Furie,Fernanda Payan-Schober,William F. Pendergraft,Elizabeth A. McInnis,Jill P. Buyon,Michelle A. Petri,Chaim Putterman,Kenneth C. Kalunian,E. Steve Woodle,James A. Lederer,David A. Hildeman,Chad Nusbaum,Soumya Raychaudhuri,Matthias Kretzler,Jennifer H. Anolik,Michael B. Brenner,David Wofsy,Nir Hacohen,Betty Diamond,

DOI: https://doi.org/10.1038/s41590-019-0398-x

IF: 30.5

2019-06-17

Nature Immunology

Abstract:Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control subjects using single-cell RNA sequencing. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid cells, T cells, natural killer cells and B cells that demonstrated both pro-inflammatory responses and inflammation-resolving responses. We found evidence of local activation of B cells correlated with an age-associated B-cell signature and evidence of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, <i>CXCR4</i> and <i>CX3CR1</i>, were broadly expressed, implying a potentially central role in cell trafficking. Gene expression of immune cells in urine and kidney was highly correlated, which would suggest that urine might serve as a surrogate for kidney biopsies.

immunology
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways

Evan Der,Hemant Suryawanshi,Pavel Morozov,Manjunath Kustagi,Beatrice Goilav,Saritha Ranabothu,Peter Izmirly,Robert Clancy,H. Michael Belmont,Mordecai Koenigsberg,Michele Mokrzycki,Helen Rominieki,Jay A. Graham,Juan P. Rocca,Nicole Bornkamp,Nicole Jordan,Emma Schulte,Ming Wu,James Pullman,Kamil Slowikowski,Soumya Raychaudhuri,Joel Guthridge,Judith James,Jill Buyon,Thomas Tuschl,Chaim Putterman,

DOI: https://doi.org/10.1038/s41590-019-0386-1

IF: 30.5

2019-05-20

Nature Immunology

Abstract:The molecular and cellular processes that lead to renal damage and to the heterogeneity of lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (scRNA-seq) to renal biopsies from patients with LN and evaluated skin biopsies as a potential source of diagnostic and prognostic markers of renal disease. Type I interferon (IFN)-response signatures in tubular cells and keratinocytes distinguished patients with LN from healthy control subjects. Moreover, a high IFN-response signature and fibrotic signature in tubular cells were each associated with failure to respond to treatment. Analysis of tubular cells from patients with proliferative, membranous and mixed LN indicated pathways relevant to inflammation and fibrosis, which offer insight into their histologic differences. In summary, we applied scRNA-seq to LN to deconstruct its heterogeneity and identify novel targets for personalized approaches to therapy.

immunology
Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis

Deepak A. Rao,Arnon Arazi,David Wofsy,Betty Diamond

DOI: https://doi.org/10.1038/s41581-019-0232-6

IF: 42.439

2019-12-18

Nature Reviews Nephrology

Abstract:The immune mechanisms that cause tissue injury in lupus nephritis have been challenging to define. The advent of high-dimensional cellular analyses, such as single-cell RNA sequencing, has enabled detailed characterization of the cell populations present in small biopsy samples of kidney tissue. In parallel, the development of methods that cryopreserve kidney biopsy specimens in a manner that preserves intact, viable cells, has enabled the uniform analysis of tissue samples collected at multiple sites and across many geographic areas and demographic cohorts with high-dimensional platforms. The application of these methods to kidney biopsy samples from patients with lupus nephritis has begun to define the phenotypes of both infiltrating and resident immune cells, as well as parenchymal cells, present in nephritic kidneys. The detection of similar immune cell populations in urine suggests that it might be possible to non-invasively monitor immune activation in kidneys. Once applied to large patient cohorts, these high-dimensional studies might enable patient stratification according to patterns of immune cell activation in the kidney or identify disease features that can be used as surrogate measures of efficacy in clinical trials. Applied broadly across multiple inflammatory kidney diseases, these studies promise to enormously expand our understanding of renal inflammation in the next decade.

urology & nephrology
Group 3 Innate Lymphoid Cells Exacerbate Lupus Nephritis by Promoting B Cell Activation in Kidney Ectopic Lymphoid Structures

Feng Li,Zhou Liang,Haojie Zhong,Xinrong Hu,Ziwen Tang,Changjian Zhu,Jiani Shen,Xu Han,Ruoni Lin,Ruilin Zheng,Ruihan Tang,Huajing Peng,Xunhua Zheng,Chengqiang Mo,Peisong Chen,Xin Wang,Qiong Wen,Jianbo Li,Xi Xia,Hongjian Ye,Yagui Qiu,Jianwen Yu,Dongying Fu,Jiaqi Liu,Rong Wang,Huixin Xie,Yun Guo,Xiaoyan Li,Jinjin Fan,Qinghua Liu,Haiping Mao,Wei Chen,Yi Zhou

DOI: https://doi.org/10.1002/advs.202302804

IF: 15.1

2023-11-03

Advanced Science

Abstract:In lupus nephritis (LN), gut‐derived group 3 innate lymphoid cells (ILC3s) migrate from the small intestine to the kidney via CXCR6/CXCL16 axis, and contribute to the progression of LN, including spleen and lymph node enlargement, antibody production and renal injury. In renal ectopic lymphoid structures (ELS), ILC3s induce B cell activation in a Delta‐like1 (DLL1)/Notch‐dependent manner, accompanied by up‐regulation of Deltex1 and MAML1. Group 3 innate lymphoid cells (ILC3s) represent a new population in immune regulation, yet their role in lupus nephritis (LN) remains elusive. In the present work, systemic increases in ILC3s, particularly in the kidney, are observed to correlate strongly with disease severity in both human and murine LN. Using MRL/lpr lupus mice and a nephrotoxic serum‐induced LN model, this study demonstrates that ILC3s accumulated in the kidney migrate predominantly from the intestine. Furthermore, intestinal ILC3s accelerate LN progression, manifested by exacerbated autoimmunity and kidney injuries. In LN kidneys, ILC3s are located adjacent to B cells within ectopic lymphoid structures (ELS), directly activating B cell differentiation into plasma cells and antibody production in a Delta‐like1 (DLL1)/Notch‐dependent manner. Blocking DLL1 attenuates ILC3s' effects and protects against LN. Altogether, these findings reveal a novel pathogenic role of ILC3s in B cell activation, renal ELS formation and autoimmune injuries during LN, shedding light on the therapeutic value of targeting ILC3s for LN.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis

Alice Horisberger,Alec Griffith,Joshua Keegan,Arnon Arazi,John Pulford,Ekaterina Murzin,Kaitlyn Howard,Brandon Hancock,Andrea Fava,Takanori Sasaki,Tusharkanti Ghosh,Jun Inamo,Rebecca Beuschel,Ye Cao,Katie Preisinger,Maria Gutierrez-Arcelus,Thomas M. Eisenhaure,Joel Guthridge,Paul J. Hoover,Maria Dall’Era,David Wofsy,Diane L. Kamen,Kenneth C. Kalunian,Richard Furie,Michael Belmont,Peter Izmirly,Robert Clancy,David Hildeman,E. Steve Woodle,William Apruzzese,Maureen A. McMahon,Jennifer Grossman,Jennifer L. Barnas,Fernanda Payan-Schober,Mariko Ishimori,Michael Weisman,Matthias Kretzler,Celine C. Berthier,Jeffrey B. Hodgin,Dawit S. Demeke,Chaim Putterman,Accelerating Medicines Partnership: RA/SLE Network,Michael B. Brenner,Jennifer H. Anolik,Soumya Raychaudhuri,Nir Hacohen,Judith A. James,Anne Davidson,Michelle A. Petri,Jill P. Buyon,Betty Diamond,Fan Zhang,James A. Lederer,Deepak A. Rao

DOI: https://doi.org/10.1101/2024.01.14.575609

2024-03-09

Abstract:Lupus nephritis (LN) is a frequent manifestation of systemic lupus erythematosus, and fewer than half of patients achieve complete renal response with standard immunosuppressants. Identifying non-invasive, blood-based pathologic immune alterations associated with renal injury could aid therapeutic decisions. Here, we used mass cytometry immunophenotyping of peripheral blood mononuclear cells in 145 patients with biopsy-proven LN and 40 healthy controls to evaluate the heterogeneity of immune activation in patients with LN and to identify correlates of renal parameters and treatment response. Unbiased analysis identified 3 immunologically distinct groups of patients with LN that were associated with different patterns of histopathology, renal cell infiltrates, urine proteomic profiles, and treatment response at one year. Patients with enriched circulating granzyme B T cells at baseline showed more severe disease and increased numbers of activated CD8 T cells in the kidney, yet they had the highest likelihood of treatment response. A second group characterized primarily by a high type I interferon signature had a lower likelihood of response to therapy, while a third group appeared immunologically inactive by immunophenotyping at enrollment but with chronic renal injuries. Main immune profiles could be distilled down to 5 simple cytometric parameters that recapitulate several of the associations, highlighting the potential for blood immune profiling to translate to clinically useful non-invasive metrics to assess immune-mediated disease in LN.

Immunology
Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

Rebecca Abraham,Madeleine S Durkee,Junting Ai,Margaret Veselits,Gabriel Casella,Yuta Asano,Anthony Chang,Kichul Ko,Charles Oshinsky,Emily Peninger,Maryellen L Giger,Marcus R Clark

DOI: https://doi.org/10.1172/JCI155350

2022-07-01

Abstract:BACKGROUNDIn human lupus nephritis (LN), tubulointerstitial inflammation (TII) on biopsy predicts progression to end-stage renal disease (ESRD). However, only about half of patients with moderate-to-severe TII develop ESRD. We hypothesized that this heterogeneity in outcome reflects different underlying inflammatory states. Therefore, we interrogated renal biopsies from LN longitudinal and cross-sectional cohorts.METHODSData were acquired using conventional and highly multiplexed confocal microscopy. To accurately segment cells across whole biopsies, and to understand their spatial relationships, we developed computational pipelines by training and implementing several deep-learning models and other computer vision techniques.RESULTSHigh B cell densities were associated with protection from ESRD. In contrast, high densities of CD8+, γδ, and other CD4-CD8- T cells were associated with both acute renal failure and progression to ESRD. B cells were often organized into large periglomerular neighborhoods with Tfh cells, while CD4- T cells formed small neighborhoods in the tubulointerstitium, with frequency that predicted progression to ESRD.CONCLUSIONThese data reveal that specific in situ inflammatory states are associated with refractory and progressive renal disease.FUNDINGThis study was funded by the NIH Autoimmunity Centers of Excellence (AI082724), Department of Defense (LRI180083), Alliance for Lupus Research, and NIH awards (S10-OD025081, S10-RR021039, and P30-CA14599).
Immune landscape and the key role of APOE+ monocytes of lupus nephritis under the single‐cell and spatial transcriptional vista

Youzhou Tang,Ying Zhang,Xinyu Li,Ruoyao Xu,Ying Ji,Jishi Liu,Jianye Liu,Quan Zhuang,Hao Zhang

DOI: https://doi.org/10.1002/ctm2.1237

IF: 8.554

2023-04-08

Clinical and Translational Medicine

Abstract:Critical points: (1) Systemic lupus erythematosus is a self‐immune disease affecting multiple organs throughout the body, with lupus nephritis as the most common complication. (2) In lupus nephritis, APOE+ monocytes infiltrate the renal glomerulus and drain through newly formed lymphatic vessels. (3) Under stimulation of double‐stranded DNA, the antigen presenting function of APOE+ monocytes decreases and their ability to secrete IFNα and IFNγ is also reduced. Background Lupus nephritis (LN) is among the most common complication of systemic lupus erythematosus (SLE) with high mortality and morbidity. The analysis of LN kidney's local immune response through single‐cell and spatial transcriptome enables the study of potential therapeutic targets. Methods By single cell sequencing and spatial transcriptome, we profile cells from LN kidney and normal kidney tissues to characterize cellular composition and elucidate the potential upstream monocyte/macrophage (Mono/MΦ) initiating the auto‐immune response. After the high‐throughput synergy screening, we performed the immunofluorescence to identify the specific cells in LN patients. The function experiments were finished by flow cytometry and Elisa. Results By immunofluorescence and spatial transcriptome, we identified differential subsets of Mono/MΦ and demonstrated that they exhibit temporal expression of TIMP1, IL1B, SPP1 and APOE. With the function experiments, we found that the APOE+ Mono may be compensatorily increased in LN, and the capacity of antigen presenting was decreased with the overexpression of APOE. Furthermore, how do the LN‐specific Mono/MΦ transport in and out the glomerulus to active the local immune response remains unclear. Our results showed that lymphangiogenesis occurred in LN kidneys but not in normal kidneys, suggesting the presence of a new lymphatic vessel may serve as a 'green channel' for LN‐specific Mono/MΦ. Conclusions In LN, APOE+ Mono are compensatorily elevated, with decreased antigen presenting ability and reduced secretion of interferons. The lymphangiogenesis in LN prompts the trafficking of Mono/MΦ in LN kidney.

oncology,medicine, research & experimental
Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis

Lin Wang,Zhihua Yang,Hangxing Yu,Wei Lin,Ruoxi Wu,Hongtao Yang,Kang Yang

DOI: https://doi.org/10.3389/fimmu.2022.839197

IF: 7.3

2022-12-02

Frontiers in Immunology

Abstract:Objective: To identify potential diagnostic markers of lupus nephritis (LN) based on bioinformatics and machine learning and to explore the significance of immune cell infiltration in this pathology. Methods: Seven LN gene expression datasets were downloaded from the GEO database, and the larger sample size was used as the training group to obtain differential genes (DEGs) between LN and healthy controls, and to perform gene function, disease ontology (DO), and gene set enrichment analyses (GSEA). Two machine learning algorithms, least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature elimination (SVM-RFE), were applied to identify candidate biomarkers. The diagnostic value of LN diagnostic gene biomarkers was further evaluated in the area under the ROC curve observed in the validation dataset. CIBERSORT was used to analyze 22 immune cell fractions from LN patients and to analyze their correlation with diagnostic markers. Results: Thirty and twenty-one DEGs were screened in kidney tissue and peripheral blood, respectively. Both of which covered macrophages and interferons. The disease enrichment analysis of DEGs in kidney tissues showed that they were mainly involved in immune and renal diseases, and in peripheral blood it was mainly enriched in cardiovascular system, bone marrow, and oral cavity. The machine learning algorithm combined with external dataset validation revealed that C1QA(AUC = 0.741), C1QB(AUC = 0.758), MX1(AUC = 0.865), RORC(AUC = 0.911), CD177(AUC = 0.855), DEFA4(AUC= 0.843)and HERC5(AUC = 0.880) had high diagnostic value and could be used as diagnostic biomarkers of LN. Compared to controls, pathways such as cell adhesion molecule cam, and systemic lupus erythematosus were activated in kidney tissues; cell cycle, cytoplasmic DNA sensing pathways, NOD-like receptor signaling pathways, proteasome, and RIG-1-like receptors were activated in peripheral blood. Immune cell infiltration analysis showed that diagnostic markers in kidney tissue were associated with T cells CD8 and Dendritic cells resting, and in blood were associated with T cells CD4 memory resting, suggesting that CD4 T cells, CD8 T cells and dendritic cells are closely related to the development and progression of LN. Conclusion: C1QA, C1QB, MX1, RORC, CD177, DEFA4 and HERC5 could be used as new candidate molecular markers for LN. It may provide new insights into the diagnosis and molecular treatment of LN in the future.

immunology
Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis

Yaxi Li,Chenling Tang,Kamala Vanarsa,Nga Thai,Jessica Castillo,Gabrielle Alexis Braza Lea,Kyung Hyun Lee,Soojin Kim,Claudia Pedroza,Tianfu Wu,Ramesh Saxena,Chi Chiu Mok,Chandra Mohan

DOI: https://doi.org/10.1016/j.jaut.2023.103165

IF: 14.511

2024-01-10

Journal of Autoimmunity

Abstract:Objective To identify urinary biomarkers that can distinguish active renal involvement in Lupus Nephritis (LN), a severe manifestation of systemic lupus erythematosus (SLE). Methods Urine from 117 subjects, comprised of inactive SLE, active non-renal lupus, active LN, and healthy controls, were subjected to Proximity Extension Assay (PEA) based comprehensive proteomics followed by ELISA validation in an independent, ethnically diverse cohort. Proteomic data is also cross-referenced to renal transcriptomic data to elucidate cellular origins of biomarkers. Results Systems biology analyses revealed progressive activation of cytokine signaling, chemokine activity and coagulation pathways, with worsening renal disease . In addition to validating 30 previously reported biomarkers, this study uncovers several novel candidates. Following ELISA validation in an independent cohort of different ethnicity, the six most discriminatory biomarkers for active LN were urinary ICAM-2, FABP4, FASLG, IGFBP-2, SELE and TNFSF13B/BAFF, with ROC AUC ≥80%, with most correlating strongly with clinical disease activity. Transcriptomic analyses of LN kidneys mapped the likely origin of these proteins to intra-renal myeloid cells (CXCL16, IL-1RT2, TNFSF13B/BAFF), T/NK cells (FASLG), leukocytes (ICAM2) and endothelial cells (SELE). Conclusion In addition to confirming the diagnostic potential of urine ALCAM, CD163 , MCP1, SELL, ICAM1, VCAM1, NGAL and TWEAK for active LN, this study adds urine ICAM-2, FABP4, FASLG, IGFBP-2, SELE, and TNFSF13B/BAFF as additional markers that warrant systematic validation in larger cross-sectional and longitudinal cohorts.

immunology
Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice

Bin Li,Yanlai Tang,Xuhao Ni,Wei Chen

DOI: https://doi.org/10.3389/fgene.2020.577040

2020-11-09

Abstract:Objective: A challenging issue in the clinical management of lupus nephritis (LN) is the resistance to immunosuppressive therapy. We postulated that perturbed intrarenal immune cell landscape affected LN onset and remission induction, and shedding light on the characteristics of intrarenal immune cell infiltration could cultivate more efficient treatment regimens. Materials and methods: Genome-wide expression profiles of microarray datasets were downloaded from the Gene Expression Omnibus database. The CIBERSORT algorithm was used to analyze the intrarenal immune cell landscape, followed by Pearson correlation analysis and principal component analysis. The differentially expressed genes were identified and subjected to Gene Ontology (GO) enrichment analyses and protein-protein interaction network establishment, being visualized by Cytoscape and further analyzed by CytoHubba to extract hub genes. Hub genes were also validated in the genomic dataset from kidney biopsy-proven LN patients. Results: In addition to memory B cells, monocytes and M1 macrophages were identified as two predominantly increased intrarenal immune cell types in LN-prone NZB/W mice upon nephritis onset. Most interestingly, apart from memory B cells, monocytes and M1 macrophages proportions in kidney tissue were significantly lower in early remission mice compared with late remission mice. Furthermore, GO analysis showed that intrarenal mononuclear phagocytes triggered nephritis onset mainly via the initiation of adaptive immune response and inflammatory reaction, but this functional involvement was mitigated upon remission induction. Hub genes related to LN onset in NZB/W mice were validated in the genomic dataset from kidney biopsy-proven LN patients. Conclusion: LN characterizes aberrant mononuclear phagocytes abundance and signature upon disease onset, of which the reversal is associated with early remission induction in LN-prone NZB/W mice. Mononuclear phagocytes might be an adjunctive histology marker for monitoring disease onset and stratifying LN patients in terms of response to remission induction therapy.
Association between tubulointerstitial CD8+T cells and renal prognosis in lupus nephritis

Ti Zhang,Mengmeng Wang,Jiaxun Zhang,Xiaopian Feng,Zhengzhao Liu,Zhen Cheng

DOI: https://doi.org/10.1016/j.intimp.2021.107877

IF: 5.714

2021-10-01

International Immunopharmacology

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>Inflammatory cell infiltration is a pathological change commonly seen in renal biopsies from patients with lupus nephritis (LN), but its clinical correlation with clinical parameters and prognosis is unclear.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Included in this retrospective study were 197 patients with ISN/ RPS Class III-V LN, in whom renal biopsy was performed to analyze the histological pattern. Tubulointerstitial infiltrates were quantitated by standard histochemical staining. Clinical and histologic variables were evaluated using a Cox proportional hazards model. End-stage renal disease (ESRD) progression was defined as a two-fold increase in serum creatinine (SCr) after biopsy, GFR decreased over 40%, initiation of dialysis, transplantation, or death.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of the 197 patients, 166 patients (84.3%) had proliferative LN. The number of tubulointerstitial infiltrates was the lowest in LN patients with ISN/RPS class V, and the number of CD68+ macrophages was the highest in all ISN/RPS classes of LN. In addition, the number of CD8+T cell infiltrates was positively correlated the SLEDAI sore, SCr level, proteinuria, the ratio of glomerulosclerosis and the degree of tubulointerstitial inflammation, interstitial fibrosis and tubular atrophy, activity and chronicity indices, and negatively correlated with C3 level at presentation. Multivariate survival analysis showed that tubulointerstitial CD8 + T cells > 130/mm<sup>2</sup> was associated with ESRD progression (HR 1.007; 95% CI 1.003 to 1.011; p < 0.001).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Tubulointerstitial CD8+T cells correlate with clinicohistologic impairment in LN. Tubulointerstitial CD8+T cells > 130/mm<sup>2</sup> is independently associated with an unfavorable long-term kidney outcome.</p>

pharmacology & pharmacy,immunology
Imbalance of programmed cell death patterns mediated by dendritic cell subsets in systemic lupus erythematosus and lupus nephritis

Ruoyao Xu,Ying Zhang,Qingtai Cao,Sheng Liao,Youzhou Tang,Quan Zhuang

DOI: https://doi.org/10.11817/j.issn.1672-7347.2024.230508

2024-03-28

Abstract:Objectives: Abnormal programmed cell death in immune cells is associated with autoimmune diseases, but the patterns of programmed cell death in systemic lupus erythematosus (SLE) and especially lupus nephritis (LN) remain unclear. This study aims to explore the association between SLE, LN, and immune cell death patterns. Methods: Bulk RNA sequencing (bulk RNA-seq) and single-cell RNA sequencing (scRNA-seq) data were downloaded from the Gene Expression Omnibus (GEO) database. Bioinformatic analysis was conducted to explore the expression levels of genes related to 3 cell death patterns in peripheral blood mononuclear cells of SLE patients. Key cell subsets involved in the imbalance of cell death patterns were identified through scRNA-seq. Immunofluorescence was used to detect the expression levels of receptor interacting serine/threonine kinase 3 (RIPK3), mixed-lineage kinase domain-like protein (MLKL), phosphorylated MLKL (pMLKL), caspase 1 (CASP1), CD1c molecule (CD1C), C-type lectin domain containing 9A (CLEC9A), and X-C motif chemokine receptor 1 (XCR1) in dendritic cells (DC). scRNA-seq was performed on kidney tissues collected from LN patients and healthy controls (HC) at the Third Xiangya Hospital of Central South University, followed by bioinformatic analysis to identify key cell subsets involved in the imbalance of cell death patterns. Pseudotime analysis and ligand-receptor analysis were used to explore the differentiation direction and cell communication of different DC subsets. Transient transfection was used to transfect RAW264.7 cells with empty plasmid, empty plasmid+dsDNA (HSV-DNA), empty plasmid+200 μmol/L tert-butyl hydroperoxide (TBHP), stimulator of interferon genes (STING) shRNA plasmid, STING shRNA plasmid+dsDNA (HSV-DNA), and STING shRNA plasmid+200 μmol/L TBHP. Annexin V-mCherry and SYTOX Green staining were used to detect cell death in each group. Western blotting was used to detect the activation of CASP1, gasdermin D (GSDMD), RIPK3, and MLKL in each group. Results: Bioinformatic analysis showed an imbalance in 3 cell death patterns in SLE and LN patients: Pro-inflammatory pyroptosis and necroptosis were activated, while anti-inflammatory apoptosis was inhibited. The key cell subsets involved were DC subsets, particularly focusing on CLEC9A+cDC1. Immunofluorescence results showed that the expression levels of RIPK3, MLKL, and CASP1 in DCs were higher in the SLE group compared to the HC group. pMLKL and CASP1 expression levels in renal cDC1 marked by CLEC9A and XCR1 were higher in the LN group than in the HC group. Pseudotime analysis and ligand-receptor analysis suggested that the CLEC9A+cDC1 subset in LN kidney tissues originated from peripheral circulation. Annexin V-mCherry and SYTOX Green staining results showed that the number of dead cells decreased in the STING shRNA transfection group compared to the empty plasmid group in RAW264.7 cells. Western blotting results showed that the activation of CASP1, GSDMD, RIPK3, and MLKL was decreased in the STING shRNA transfection group compared to the empty plasmid group. Conclusions: This study provides novel insights into the role of CLEC9A+cDC1 in the imbalance of cell death patterns in SLE and LN.

A SIMPLE PROCEDURE FOR LARGE‐SCALE DENSITY SEPARATION OF BONE MARROW CELLS FOR TRANSPLANATION

THU0247 LRRN4: A NOVEL PROGNOSTIC BIOMARKER OF RENAL OUTCOME IN LUPUS NEPHRITIS PATIENTS

p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation

A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis

TLR4+CXCR4+ Plasma Cells Drive Nephritis Development in Systemic Lupus Erythematosus

Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics

Optimization of the design for beamline with fast polarization switching elliptically polarized undulators.

The immune cell landscape in kidneys of patients with lupus nephritis

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways

Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis

Group 3 Innate Lymphoid Cells Exacerbate Lupus Nephritis by Promoting B Cell Activation in Kidney Ectopic Lymphoid Structures

Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

Immune landscape and the key role of APOE+ monocytes of lupus nephritis under the single‐cell and spatial transcriptional vista

Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis

Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis

Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice

Association between tubulointerstitial CD8+T cells and renal prognosis in lupus nephritis

Imbalance of programmed cell death patterns mediated by dendritic cell subsets in systemic lupus erythematosus and lupus nephritis